ATLANTA, GA – – (Newsfile Corp. – January 25, 2021) – – Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Voyager Therapeutics, Inc.  (“Voyager” or the “Company”) (NASDAQ: VYGR) securities between June 1, 2017 and November 9, 2020, inclusive (the “Class Period”). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the Company’s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls (“CMC”) matters; (2) the Company’s IND submission for VY-HTT01 was therefore deficient; (3) the Company had thus materially overstated the likelihood of FDA approval for VY-HTT01 based on the IND submission; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. If you purchased shares of Voyager securities between June 1, 2017 and November 9, 2020 and suffered significant losses on that investment, you are encouraged to contact Marshall P. Dees, Esq. at mdees@holzerlaw.com or Luke R. Kennedy, Esq. at lkennedy@holzerlaw.com, by toll-free telephone at (888) 508-6832 or through www.holzerlaw.com to discuss your legal rights.

Provide Your Information To Take Action

  • Plaintiff Certifies That:
    1. Plaintiff has reviewed the complaint and authorized its filing.
    2. Plaintiff did not acquire the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this private action or any other litigation under the federal securities laws.
    3. Plaintiff is willing to serve as a representative party on behalf of a class, including providing testimony at deposition and trial, if necessary.
    4. Plaintiff represents and warrants that he/she/it is fully authorized to enter into and execute this certification.
    5. Plaintiff will not accept any payment for serving as a representative party on behalf of a class beyond the Plaintiff's pro rata share of any recovery, except such reasonable costs and expenses (including lost wages) directly relating to the representation of the class as ordered or approved by the court.
    6. Plaintiff has made no transaction(s) during the Class Period in the debt or equity securities that are the subject of this action except those set forth below:
  • Date PurchasedNumber of Shares AcquiredAcquisition Price Per Share 
  • Date SoldNumber of Shares SoldSelling Price Per Share 
  • Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt